SIC
CLB icon

Salem Investment Counselors’s Core Laboratories CLB Stock Holding History

Salem Investment Counselors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,000
Closed -$198K – 1047
2022
Q2 		$198K Hold
10,000
– – 0.01% 325
2022
Q1 		$316K Hold
10,000
– – 0.01% 295
2021
Q4 		$223K Hold
10,000
– – 0.01% 358
2021
Q3 		$278K Hold
10,000
– – 0.02% 303
2021
Q2 		$390K Hold
10,000
– – 0.02% 264
2021
Q1 		$288K Hold
10,000
– – 0.02% 254
2020
Q4 		$265K Buy
+10,000
New +$204K 0.02% 252

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Salem Investment Counselors's CLB Position: Q3 2022 in Review

Salem Investment Counselors sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 10,000 shares — an estimated $198K sold.

Salem Investment Counselors first reported a position in CLB in Q4 2020 and held it in 7 quarters. The position peaked at $390K in Q2 2021. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

  • Salem Investment Counselors reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
  • Salem Investment Counselors sold 10,000 Core Laboratories shares in Q3 2022, an estimated $198K.
  • Salem Investment Counselors first reported a position in Core Laboratories in Q4 2020 and held it in 7 quarters.
  • Salem Investment Counselors's Core Laboratories position peaked at $390K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Salem Investment Counselors's 13F filing for Q3 2022, filed 9 Nov 2022.